CCDS | Jotup

PrepMD Partners with MediaSphere and Esteemed Cardiac Experts for Groundbreaking Virtual Device Clinic Leadership Summit

Retrieved on:

Wednesday, February 21, 2024

Consensus, FHRS, MSN, RN, Participation, HRS, Curriculum, Faculty, Heart Rhythm Society, CCDS, Business, Biotronik, Health, Journal, Atrium Health, Partnership

BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.

Key Points:

BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.
The summit aims to gather leading experts in cardiac device clinic management for a deep dive into pivotal topics.
The summit is privileged to feature a panel of esteemed faculty members, each recognized for their significant contributions to cardiac care:
Beth Davenport, MSN, RN, Clinical Translation Specialist at Biotronik (Former Director of Virtual Care and Cardiac Device Clinic, Sanger Heart & Vascular ), Charlotte, NC
Sallie Gustafson, RN, Manager of Device Clinic at Emory Clinic, Emory Healthcare , Atlanta, GA
Nancy Lee, RN, FHRS, CCDS, Regional Director of Device Operations, Clinical Arrhythmia Device Nurse, Prairie Cardiovascular Consultants, Ltd. , O'Fallon, IL
Amy Tucker, MSN, RN, CCDS, Nurse Manager, Cardiac Device Clinic, Sanger Heart & Vascular Institute , Charlotte, NC
The Device Clinic Summit is an essential event for all involved in cardiac device clinic management, offering a crucial forum for improving practices and patient care.
For registration and additional details, please visit the official website of the summit , hosted by The Journal of Innovations in Cardiac Rhythm Management™.

Celegence Launches “CAPTIS™ Copilot,” the Most Advanced AI Compliance Solution for Device and Diagnostic Manufacturers

Retrieved on:

Wednesday, August 2, 2023

Celegence , a regulatory compliance service and software solution company, today announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry.

Key Points:

Celegence , a regulatory compliance service and software solution company, today announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry.
CAPTIS Copilot is an enterprise cloud-based platform leveraging pre-trained large language models (LLM) and Reinforcement Learning from Human Feedback (RLHF) for the device and diagnostic industry.
This cloud-based solution significantly advances the ability of device and IVD manufacturers to increase innovation and empower clinical, regulatory, and medical writing teams to be more strategic and productive with their time.
Celegence has also initiated the usage of CAPTIS’ AI assistant for pharmaceutical and biologic medical writing activities, such as CCDS and SmPCs.

Leaders from University Hospitals and MCG to Speak at Ohio Hospital Association Annual Meeting

Retrieved on:

Tuesday, June 6, 2023

MCG, Collaborative Care, University Hospitals Cleveland Medical Center, Health, CCDS, BSN, Teaching hospital, Hearst Communications, RN, OHA, Utilization management, Nursing

COLUMBUS, Ohio, June 6, 2023 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces its Product Manager for Interoperability Solutions, Daniel Cawood, will co-present with University Hospitals' Director of Clinical Documentation Integrity & Utilization Management, Kelly Skorepa, BSN, RN, CCDS, at the Ohio Hospital Association's (OHA) 108th Annual Meeting & Education Summit happening June 12-14, 2023, at the Hilton Columbus at Easton in Columbus, Ohio.

Key Points:

Ms. Skorepa and Mr. Cawood will present the session, "Fostering Payer-Provider Collaboration to Reduce Administrative Burden," on Tuesday, June 13, from 9:45 a.m. to 10:45 a.m.
These experts from University Hospitals and MCG, respectively, will provide a before-and-after analysis of leveraging MCG Indicia for Collaborative Care to streamline the clinical authorization processes with payers.
The speakers will detail the challenges University Hospital faced prior to launching the solution, important aspects of the implementation process, and the subsequent results of using the solution - including time-savings and hospital productivity metrics.
Mr. Cawood said of the presentation, "MCG and University Hospitals have a compelling story to share about new technology that is automating clinical authorizations and making a powerful impact on hospital efficiency."

The Worldwide Nucleic Acid Sample Preparation Industry is Projected to Reach $11.2 Billion by 2032 - ResearchAndMarkets.com

Retrieved on:

Tuesday, February 7, 2023

Biotechnology, Genetics, Health, Stem Cells, DNA, CCDS, Long-string instrument, Agilent Technologies, Workflow, QIAGEN, GENCODE, NGS, TERT, Face, Exon, Chemistry, HMW, RefSeq, OGM, UHMW, Fine chemical, Vaccine, Tecan

and Bionano Genomics created a Long String VANTAGE, a brand-new DNA extraction automation product.

Key Points:

and Bionano Genomics created a Long String VANTAGE, a brand-new DNA extraction automation product.
Ultra-high molecular weight (UHMW) DNA can be extracted with the instrument and used for optical genome mapping (OGM).
As a requirement for the sample preparation workflow at Bionano Genomics, high-quality and quantity UHMW DNA extraction is required.
The following are the demand drivers for the global nucleic acid sample preparation market:
The market is expected to face some limitations due to the following challenges:

Insights on the Nucleic Acid Sample Preparation Global Market to 2032 - Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas Fuels Growth

Retrieved on:

Wednesday, February 8, 2023

DNA, CCDS, Long-string instrument, Agilent Technologies, Workflow, QIAGEN, GENCODE, NGS, TERT, Face, Research, Exon, Chemistry, HMW, RefSeq, OGM, UHMW, Fine chemical, Tecan

In 2021, the North America nucleic acid sample preparation market dominated the global market with a 46.99% market share, and it is expected to hold its dominance throughout the forecast period 2022-2032.

Key Points:

In 2021, the North America nucleic acid sample preparation market dominated the global market with a 46.99% market share, and it is expected to hold its dominance throughout the forecast period 2022-2032.
However, the Asia-Pacific (APAC) region, constituting several emerging economies, is expected to register the highest CAGR of 12.01% during the forecast period 2022-2032.
As a requirement for the sample preparation workflow at Bionano Genomics, high-quality and quantity UHMW DNA extraction is required.
Increased demand for high-quality reagents, kits, and related items has resulted from advancements in the nucleic acid sample preparation procedure.

The nation's clinical documentation integrity professionals will converge on Chicago for the 2023 ACDIS national conference, themed Flourish: CDI In Bloom

Retrieved on:

Monday, February 6, 2023

BRENTWOOD, Tenn., Feb. 6, 2023 /PRNewswire-PRWeb/ -- The Association of Clinical Documentation Integrity (ACDIS) is holding its 2023 national conference May 8–11 at the Hyatt Regency in Chicago, Illinois. The 2023 ACDIS national conference provides opportunities for attendees to flourish personally and professionally in their clinical documentation integrity (CDI) role. With five tracks of unparalleled education, there are more than 50 sessions for attendees to choose from to nourish their professional soul, cultivate plans for personal and staff development, and create a CDI program that will blossom.

Key Points:

BRENTWOOD, Tenn., Feb. 6, 2023 /PRNewswire-PRWeb/ -- The Association of Clinical Documentation Integrity (ACDIS) is holding its 2023 national conference May 8–11 at the Hyatt Regency in Chicago, Illinois.
The 2023 ACDIS national conference provides opportunities for attendees to flourish personally and professionally in their clinical documentation integrity (CDI) role.
Starting on Tuesday, May 9, there will be lunch discussion groups dedicated to outpatient CDI, pediatric CDI, CDI educators/second-level reviewers, and new/aspiring leaders.
To learn more about the 2023 ACDIS conference, visit https://www.acdis.org/2023conference or contact a Customer Service representative at 800-650-6787 x4005 and [email protected] .

BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

Retrieved on:

Tuesday, December 6, 2022

PURE EP™’s HFA signal analysis was observed alongside the simultaneous signal anno New Primary Logo New Primary Logo tation produced by a 3D mapping system.

Key Points:

PURE EP™’s HFA signal analysis was observed alongside the simultaneous signal anno New Primary Logo New Primary Logo tation produced by a 3D mapping system.
PURE EP™’s real-time HFA identified early local activation, providing a clear and precise location that served as the primary target for ablation therapy during the procedure.
By removing unnecessary distractions, the PURE EP™ System with HFA preserves the value of cardiac signals and delivers clear, actionable insights to today’s electrophysiologist.
1 Koch W. Zachary; Chung, Roy (2022), Confirmation of Acute Pulmonary Vein Reconnection with Case Report: The Utilization of PURE EP’s High-Frequency Algorithm (HFA), Journal of Atrial Fibrillation & Electrophysiology, Volume 15, Issue 6, Nov 2022. https://jafib-ep.com/journal/volume-15-issue-6-nov-2022/confirmation-of-...
2 Global Market Insights Inc. March 08, 2022.

Enjoin Announces Expansion of Solutions Portfolio

Retrieved on:

Thursday, October 6, 2022

COLLIERVILLE, Tenn., Oct. 6, 2022 /PRNewswire/ -- Enjoin, a physician-directed mid-revenue cycle solutions provider, announced today expansion of its services portfolio to include Workforce Solutions to support healthcare organizations with Clinical Documentation Specialists, Inpatient Clinical Coders, Case Managers, and Utilization Review Nurses. This announcement precedes Enjoin's participation at the AHIMA22 Global Conference in Columbus, OH next week.

Key Points:

COLLIERVILLE, Tenn., Oct. 6, 2022 /PRNewswire/ -- Enjoin , a physician-directed mid-revenue cycle solutions provider, announced today expansion of its services portfolio to include Workforce Solutions to support healthcare organizations with Clinical Documentation Specialists, Inpatient Clinical Coders, Case Managers, and Utilization Review Nurses.
Enjoin adds Workforce Solutions to mid-revenue cycle services portfolio.
Adding staffing to our portfolio was a natural transition and complements Enjoin's trusted and verified quality brand supporting clients with high value, high impact results.
Enjoin earned an A+ rating in the First Look by KLAS for its clinical documentation integrity services.

ProVantaCare Launches eAccessTM Physical Health and Analytics Resource

Retrieved on:

Tuesday, September 20, 2022

HARRISBURG, Pa., Sept. 20, 2022 /PRNewswire/ -- ProVantaCare has announced the official launch of eAccessTM, a groundbreaking platform to assist health and human services providers with obtaining and analyzing physical health data.

Key Points:

HARRISBURG, Pa., Sept. 20, 2022 /PRNewswire/ -- ProVantaCare has announced the official launch of eAccessTM, a groundbreaking platform to assist health and human services providers with obtaining and analyzing physical health data.
ProVantaCare is a network of over 80 leading health and human service providers supporting individuals across the Commonwealth.
As a contracting entity, ProVantaCare provides advantages to its provider-owners and delivery of improved care through innovative models that enhance health outcomes and services.
ProVantaCare brings together this network of providers to coordinate and improve the health and well-being of the individuals we support.

PaceMate™ Co-Founders to Speak at HRX 2022, the Heart Rhythm Society's Cardiovascular Digital Health Summit

Retrieved on:

Wednesday, August 17, 2022

TAMPA, Fla., Aug. 17, 2022 /PRNewswire/ -- PaceMate, one of the nation's fastest-growing cardiac rhythm management and remote patient monitoring companies, announced two of its co-founders have been chosen to speak at HRX 2022, the Heart Rhythm Society's cardiovascular digital health summit on September 8-10, 2022, in San Diego, California.

Key Points:

TAMPA, Fla., Aug. 17, 2022 /PRNewswire/ -- PaceMate, one of the nation's fastest-growing cardiac rhythm management and remote patient monitoring companies, announced two of its co-founders have been chosen to speak at HRX 2022, the Heart Rhythm Society's cardiovascular digital health summit on September 8-10, 2022, in San Diego, California.
The first annual innovation-focused digital cardiovascular summit brings together 500 national innovators, including clinicians, engineers, product developers, investors, entrepreneurs, nonprofits, and patient advocacy groups, to examine transformative digital health trends and solutions to improve cardiovascular patient care.
"I am honored to be selected to speak at the Heart Rhythm Society's HRX digital health summit," said Tripp Higgins, CEO of PaceMate.
Incorporated in 1979 and based in Washington, D.C., it has a membership of more than 7,500 heart rhythm professionals in more than 90 countries worldwide.